early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer...
TRANSCRIPT
![Page 1: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/1.jpg)
Early diagnosis of lung cancerDr. Frank Sullivan, FRSE, FRCP, FRCGP, CCFP
Physicians Services Incorporated Northern Ontario School of Medicine Visiting Scholar
Family Physician Family Medicine Teaching Unit, NYGHGordon F. Cheesbrough Research Chair and Director of UTOPIAN
Professor, Department of Family & Community Medicine andDalla Lana School of Public Health, University of Toronto.
Honorary Professor, University of Dundee.
![Page 2: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/2.jpg)
Conflict of Interest Statement
• I declare that I have no financial or other conflicts of interest and that I have no relationships with any commercial interests.
![Page 3: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/3.jpg)
Michael Doherty• October: A 56 year old factory worker consults his family
physician with a smoker’s cough that has been a bit worse than normal over the past week. He is otherwise well and there are no abnormal physical findings. His symptoms respond to a one week course of Amoxicillin.
• January: Normally the life and soul of the party he had been more subdued over the holidays. His wife persuades him to go back to his physician who arranges a CXR. After an initially suspicious result further tests confirm a stage III small cell lung cancer.
• May: Stops work and starts palliative care.• October: Dies leaving his widow with 5 children still at
school
![Page 4: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/4.jpg)
The next 50 minutes
• Problem of Late Diagnosis
• Options for Earlier Diagnosis– More Effective Treatment
• A Large Trial in Scotland– Practice Based Research Networks
• Further work in Canada
![Page 5: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/5.jpg)
7,000
7,500
8,000
8,500
9,000
9,500
Prostate Breast Lung Colon & rectum
New cases of Cancer in Ontario 2009
0.7 cases per 1000 patients
![Page 6: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/6.jpg)
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
Lung Colon &rectum
Breast Pancreas Prostate
Deaths from cancers in Ontario 2009
Poor prognosis: ~16% five-year survival, mostly due to late detection.Prognosis improves if cancer is found at an early stage:
•80-90% 5-year survival (Stage 1) •Median survival of 6 months (Stage 4)
![Page 7: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/7.jpg)
Geographical Variation in incidence
![Page 8: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/8.jpg)
European Age-Standardised Mortality Rates by Deprivation Quintile, England
Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.
![Page 9: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/9.jpg)
Percentage of respondents who smoke by Scottish Index of Multiple Deprivation2009/2010 data,
cotland's People Annual report: Results from 2009/2010 Scottish Household Survey
![Page 10: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/10.jpg)
Not just smoking – diet and environment.
0
100
200
300
400
500
0 10 20 30 40
Average number of cigarettes smoked daily
Aver
age
annu
al d
eath
rate
per
100
,000 West of Scotland
UK doctors American Cancer Society volunteers
US veterans
![Page 11: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/11.jpg)
![Page 12: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/12.jpg)
Diagnosis is exceptionally difficult when the background risk is low.
Clinical features of limited value: 80% present at a late stage,
Positive predictive values (PPVs) for lung cancer for individual risk markers and for pairs of risk markers in combination (background risk of 1.8 per 1000) Howie JG (1972) Diagnosis : the Achilles heel? J R Coll Gen Pract 1972:310–315
Hamilton W et al. Thorax 2005;60:1059-1065.
![Page 13: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/13.jpg)
% 5 year survival by TNM staging (UK)
Staging Non small cell Small cell
1A 58-73 38
1B 43-58 21
2A 36-46 38
2B 25-36 18
3A 19-24 13
3B 7-9 9
4 2-13 1
80%
20%
![Page 14: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/14.jpg)
Will lung cancer become a chronic disease if detected early?
Nature Oncology Reviews 2015
![Page 15: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/15.jpg)
![Page 16: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/16.jpg)
Cumulative number of lung cancer deaths recorded by the NLST
NEJM 2011
53,454 persons at high risk for lung cancer
3 Annual CT Scans
20% ReductionIn Mortality
![Page 17: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/17.jpg)
Canadian Task Force on Preventive Health Care 2016 Lung Cancer Screening
Recommendations
![Page 18: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/18.jpg)
Cancer detection and harms - NLST(averaged over 3 annual lung screens)
• 11.2% of screens were followed by one or more extra scan (additional radiation 7-10mSv compared to 0.5mSv with CXR).
• 0.9% of screens led to diagnosis of lung cancer (10-15% of which would not have appeared during remaining life).
• 0.5% of screens led to biopsy or bronchoscopy that did NOT find cancer.
• 0.3% of screens led to surgery that did not reveal lung cancer.
![Page 19: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/19.jpg)
Potential Roles of Biomarkers in Lung cancer
Identify high risk subjects
Initial assessment of risk with Biomarker
CT Scan
Biomarkers to define lesions
Biomarkers to Target Rx
![Page 20: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/20.jpg)
A Review of Blood-Based Biomarkers – Gavin Chu FY2
• 3 biomarker signatures in Phase 4 testing:– EarlyCDT-lung (antibody based assay)– miR-test (serum-based 34 miRNA signature), – MSC (plasma-based miRNA) test
• Key questions: 1. Diagnostic performance of biomarker test individually?2. Diagnostic performance of each biomarker test used in
conjunction with LDCT? 3. Any data in improving lung-cancer mortality and all-cause
mortality?
![Page 21: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/21.jpg)
Literature Review
![Page 22: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/22.jpg)
Results: Diagnostic Performance Individually
Test EarlyCDT-lung MSC miR-testSensitivity 41%
(95% CI: 29-53%)87% (95%CI: N/A)
78% (95%CI: N/A)
Specificity 87% (95% CI: 86-89%)
81% (95% CI: 79-84%)
75% (95% CI: 72-78%)
PPV 11% (95% CI: 7-15%)
27% (95% CI: 21-32%)
10% (95% CI: 7-14%)
NPV 97% (95% CI: 97-98%)
98% (95% CI: N/A)
98% (95% CI: N/A)
Positive LR 3.19 4.67 3.09
Negative LR 0.68 0.16 0.30
![Page 23: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/23.jpg)
Rationale for the detection of Autoantibodies
Auto-Immune response Circulating Auto-antibodies
Small [Auto-antigen] Large [Auto-antibody]
Aberrant molecule Auto-Antigen
Auto-Antigen Auto-Immune response
Small tumour bulk Measurable signal
![Page 24: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/24.jpg)
CT EarlyCDT-Lung
CT-False Positives
-Radiation Exposure-Increased number of anxious patients
EarlyCDT-Lung-5X better PPV and 7X fewer False Positives
-Non-invasive & less radiation risk
EarlyCDT-Lung concentrates 41% of the lung cancers in 8% of a high risk populationAssuming a 2% prevalence of lung cancer in a high risk population of 1000 patients…
69 patients will undergo unnecessary follow-up; 8 identified immediately, 8 more over next 2 years
*Performance of CT has been reported as 50% specificity and 70% sensitivity (Swensen et al 2002, 2005 & van Klausen et al 2009)*EarlyCDT-Lung has been shown to reported to have a 87% specificity & 41% sensitivity
Negative Result
False Positive
Detected Lung Cancer
490 patients will undergo unnecessary follow-up; 14 lung cancer identified
![Page 25: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/25.jpg)
Phases of biomarker development
Margaret Sullivan Pepe et al. JNCI J Natl Cancer Inst 2001;93:1054-1061
![Page 26: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/26.jpg)
![Page 27: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/27.jpg)
Research Question
Is the EarlyCDT™Lung test effective in reducing the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical practice?
$8M
![Page 28: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/28.jpg)
![Page 29: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/29.jpg)
Why do we need a trial?
![Page 30: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/30.jpg)
Practice Based Research Networks
![Page 31: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/31.jpg)
![Page 32: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/32.jpg)
ECLS Study Subjects
• Electronic Medical Records Screened by PBRN– practices from most deprived
quintile (200)
• Greater Glasgow & Clyde
• Tayside
• Lanarkshire
• High risk(2%) patients aged 50-75
– Current and recent smokers
• 20 pack years
– Family history Lung Ca
– ECOG 1&2
![Page 33: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/33.jpg)
Identifying patients at practice level n=5 437
3 837960640
![Page 34: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/34.jpg)
Additional recruitment Strategies
•Awareness raising•Practice letters & Calls•GP computer based reminders
•Public spaces
![Page 35: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/35.jpg)
% Participants from eligible
If 60 practices need 26% participationIf 80 Practices need 20% participation
Pilot work in 4 deprived areas 34-42% say they would participate
![Page 36: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/36.jpg)
Methods- In BriefObjective
to assess the effectiveness of EarlyCDTLung test in reducing the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical practice.
Intervention7 Antigen Early-CDT™ lung testIf +ve CT scan, baseline then 6 monthly for 24 months(If –ve, no active surveillance, outcome data at 24 months)
Primary OutcomeDifference at 24 months after randomisation, between the number of patients with stage 3, 4 or unclassified lung cancer at diagnosis in the intervention arm, and those in the control arm in Scottish Cancer Registry.
![Page 37: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/37.jpg)
ECLS Imaging
• Participants with positive test and a CXR that does not show malignancy will proceed to have 6 monthly CT chests for 24 months
![Page 38: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/38.jpg)
Secondary Outcomes
• Costs– Health Service– Societal
• Longer follow up using Record Linkage– 5 years – 10 years
• Harms– 2PhDs on psychological & behavioural responses
![Page 39: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/39.jpg)
Progress with an RCT of the detection of autoantibodies to tumour antigens in lung cancer using the EarlyCDT-Lung test in Scotland Dr. Frank Sullivan
Power• With a sample size of 10,000 and • a baseline annual late stage presentation rate of
1 200/100 000 = 1.2% and • risk differences of 30%, 35% and 40% provide• powers 0.71, 0.82 and 0.93 respectively with two-sided
alphas of 0.05.
Annual Incidence of late stage cancer lower than anticipated in 1st 2 years
– 680/100 000 instead of 1 200/100 000– Target increased to 12 000
![Page 40: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/40.jpg)
Subjects vs Patients
• Subjects• People in the study• Positive EarlyCDT
test• Normal CT or • Small pulmonary
nodules• Looked after by the
study
• Patients
• Positive EarlyCDT test
• Obvious tumour on CXR or CT
• Large pulmonary nodules
• Looked after by NHS
![Page 41: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/41.jpg)
Progress 7.8.13- 31.5.16
• 12 005 Randomised(1:1)• 572/5986 (9.6%) tests positive
– 558 have had a CXR and 1st CT– 18 have had 24 month CT– 190 had one or more pulmonary nodules
• 263 incidental findings• 27/251 nodules (1.1%) suspicious so far • 16 participants in test arm confirmed as cancer so far
(one with 2 primary lesions).• 4/17 (24%) cancers late stage(3, 4 or unclassified)
![Page 42: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/42.jpg)
Partial Consort Diagram12 005
5 986 tested 6 022 control
572 positive
CXR/CT 116 abnormal
5 414 negative/pending
Multidisciplinary team process
100 nodules etc.
17 cancers, 13 operable
6 monthly Follow up
![Page 43: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/43.jpg)
Provisional conclusions from early data
• GP Electronic Medical Record data able to identify >77K potential study subjects
• 16% Very hard to reach study subjects recruited• Lower than expected annual incidence of late
stage cancer - 680/100 000 not 1 200/100 000– Healthy Volunteer Effect
• Higher than expected Risk Difference 24% late stage not 80%
• Final results expected late 2018/early 2019
![Page 44: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/44.jpg)
Estimate of test performance based on incomplete data
• Specificity - 90.7%• Sensitivity - 81.3% • PPV 2.8• NPV 99.9• Likelihood ratio of a positive test 8.8• Likelihood ratio of a negative test 0.2
• Current estimates likely to overestimatesensitivity and LR+ve
![Page 45: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/45.jpg)
Michael Doherty• October: A 56 year old factory worker consults his family
physician with a smoker’s cough that has been a bit worse than normal over the past week. He is otherwise well and there are no abnormal physical findings. His symptoms respond to a one week course of Amoxicillin.
• October: His biomarker result returns with a positive test• November: His CT scan shows a suspicious nodule.• January: He has a partial lobectomy for a stage 2a small
cell cancer• April: Returns to work a non-smoker.• July: Goes on holiday with his family.
![Page 46: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/46.jpg)
![Page 47: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/47.jpg)
![Page 48: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/48.jpg)
Planned Ontario Screening pathwayHigh risk
? Add biomarkerin a trial
![Page 49: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/49.jpg)
Research Question – Lead Mary Ann O’Brien
• What are the views of PCPs on their potential roles and informational needs in an organized LDCT screening program?
![Page 50: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/50.jpg)
Methods
• Sampled PCPs from diverse health regions of Ontario and different practice models including family health teams and community health centres
• Conducted focus groups using modified Delphi method
• Developed a coding scheme then applied it systematically to interview transcripts
![Page 51: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/51.jpg)
Results
Four groups with 33 PCPs and staff:– 27 (82%) female; – 21 (64%) physicians, – 6 (18%) other health professionals, – 6 (18%) administrative staff
![Page 52: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/52.jpg)
Theme #1Variable involvement of PCPs in identifying eligible patients for LDCT screening
– Greater involvement: e.g., running searches on EMR, applying algorithm, discussing pros and cons of LDCT
– Generally Supportive
– Lesser involvement: e.g., advertising screening in office
– Concerned about additional workload
Sample Quotations
“… I think we could very well be involved because our EMRs, we target smokers and we can run searches on our EMRs to find patients, exactly the ones you’re looking for, so... we do it for other, you know... for all the big four, colon cancer and so on.”
“[In] 10 to 15 minutes I cannot see myself conscientiously committing to doing anything else … I like our reminders… of the PAPs, the mammograms, the faecal occult blood. This could certainly be something else that’s there. But I cannot conscientiously say that I’m going to be able to do this.”
![Page 53: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/53.jpg)
![Page 54: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/54.jpg)
Theme #2Responsibility for follow up of positive LDCT findings should rest with a screening program not PCPs
Sample Quotation
“I, as a family doctor, would like to know that there was a 4 mm lesion found, it’s been reviewed by a thoracic surgeon…and the recommendations are there.”
![Page 55: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/55.jpg)
Theme #3Smoking cessation services are a key component of a lung cancer screening program
Sample Quotation
“… this is a phenomenal opportunity for those people who are identified as not being eligible for the low dose CT to have a discussion regarding smoking cessation. That’s absolutely crazy not to use this as an opportunity.”
![Page 56: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/56.jpg)
Theme #4
PCPs have high information needs• Evidence including potential benefits and harms
such as false positive results • Eligibility criteria
• High risk• Identification of patients with multi-morbidities
• Details of a proposed screening process• Communicating risk information to patients • Follow up process when patients receive an
abnormal result
![Page 57: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/57.jpg)
Conclusions• A future Ontario LDCT lung cancer screening
program will need to consider the wide variability in the roles that PCPs envisioned for themselves.
• As PCPs had extensive information needs, a future program will need to develop information materials and learning opportunities tailored to identified needs.
• The existence of LDCT lung cancer screening program was seen as a new opportunity to discuss smoking cessation with patients. Therefore PCPs advocated that a potential program have explicit links to smoking cessation programs.
![Page 58: Early diagnosis of lung cancer - nosm.ca · the incidence of patients with late- stage lung cancer at diagnosis, compared with standard clinical practice. Intervention. 7 Antigen](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fcf06ea906e1c4fc703a3cc/html5/thumbnails/58.jpg)
Should we nest a biomarker study in the Ontario Scheme?
• Are the Scottish results encouraging enough to consider extending to Ontario?– 76% operable V 20%
• Would EMR data quality in Canada be good enough?
• Do we need a PBRN to undertake this kind of study?
• What else would be needed?